Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
SALT LAKE CITY, Oct. 01, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and […]
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
Robust 218-patient RCT demonstrates statistically superior frequency of wound closure at 12 weeks compared to standard of care (p=.04) Organogenesis […]
Highwoods to Release Third Quarter 2024 Results Tuesday, October 22nd
Conference CallWednesday, October 23rd, at 11:00 A.M. RALEIGH, N.C., Oct. 01, 2024 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE:HIW) will […]
Great Lakes Announces Receipt of $342.3 Million in Awarded Work
HOUSTON, Oct. 01, 2024 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (NASDAQ: GLDD), […]
Diamondback Energy, Inc. Announces Revised Third Quarter Production and Capital Guidance
MIDLAND, Texas, Oct. 01, 2024 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or the “Company”) today announced revised […]
TSX News -
Gibson Energy Confirms 2024 Third Quarter Earnings Release and Provides Conference Call & Webcast Details
CALGARY, Alberta, Oct. 01, 2024 (GLOBE NEWSWIRE) — Gibson Energy Inc. (TSX:GEI) (“Gibson” or the “Company”) announced today that it expects […]
Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Announces Closing of Acquisition
MIDLAND, Texas, Oct. 01, 2024 (GLOBE NEWSWIRE) — Viper Energy, Inc. (NASDAQ:VNOM) (“Viper” or the “Company”), a subsidiary of Diamondback […]
MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall
Company to Sponsor Lunch Symposium and Hands-On Skills Lab Featuring Seven Accepted Posters, Further Expanding Its Best-In-Class Portfolio of Clinical […]
Enerflex Ltd. Announces Partial Redemption of Senior Secured Notes, Further Debt Reduction and Timing of Third Quarter Results
ISSUES NOTICE TO REDEEM $62.5 MILLION OF ITS 9.00% SENIOR SECURED NOTES DUE 2027 NET DEBT BALANCE OF APPROXIMATELY $700 […]
Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility
Investment led by healthcare-focused institutional investor with participation from SymBiosis; founding investor Kensington Capital Holdings; Clene’s Chairman of the Board of Directors, [...]
